This company is no longer active
Salud financiera de hoja de balance de Vallon Pharmaceuticals
Salud financiera controles de criterios 4/6
Vallon Pharmaceuticals has a total shareholder equity of $2.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.2M and $1.8M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$3.78m |
| Patrimonio | US$2.34m |
| Total pasivo | US$1.81m |
| Activos totales | US$4.15m |
Actualizaciones recientes sobre salud financiera
We're Keeping An Eye On Vallon Pharmaceuticals' (NASDAQ:VLON) Cash Burn Rate
Dec 15
We Think Vallon Pharmaceuticals (NASDAQ:VLON) Needs To Drive Business Growth Carefully
Aug 17Will Vallon Pharmaceuticals (NASDAQ:VLON) Spend Its Cash Wisely?
May 17Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: VLON's short term assets ($4.2M) exceed its short term liabilities ($1.8M).
Pasivo a largo plazo: VLON has no long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: VLON is debt free.
Reducción de la deuda: VLON had no debt 5 years ago.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: VLON has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: VLON has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.5% each year